Home Cart Sign in  
Chemical Structure| 2170606-74-1 Chemical Structure| 2170606-74-1

Structure of DB2313
CAS No.: 2170606-74-1

Chemical Structure| 2170606-74-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

DB2313 is a first-in-class potent small-molecule inhibitor of PU.1. DB2313 disrupts the interaction of PU.1 with target gene promoters and leads to down-regulation of canonical PU.1 transcriptional targets.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of DB2313

CAS No. :2170606-74-1
Formula : C42H41FN8O2
M.W : 708.83
SMILES Code : FC=1C(=CC=CC1COC=2C=CC(=CC2)C3=NC4=CC=C(C=C4N3)C(=N)NC(C)C)COC=5C=CC(=CC5)C6=NC7=CC=C(C=C7N6)C(=N)NC(C)C
MDL No. :N/A

Safety of DB2313

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
human monocyte-derived macrophages 0.5 μM 7 days Transdifferentiation of macrophages into neuronal cells, observed neuron-like morphology and expression of neuronal markers Front Cell Neurosci. 2023 Aug 11;17:1225504

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
BALB/c mice HDM-induced model of experimental asthma Intranasal administration 1 mg/kg and 8 mg/kg 5 days per week for 3 weeks DB2313 (8 mg/kg) decreased mucus secreting cell number, and DB2313 (1 mg/kg) reduced small airway collagen deposition. Both doses decreased airway hyperresponsiveness. Respir Res. 2023 Jan 25;24(1):32
BALB/c mice Subcutaneous xenograft model Intraperitoneal injection 10 mg/kg/day Once daily for 7 days DB2313 significantly inhibited tumor burden, increased FTO expression, and reduced Ki67 and CD44 expression Mol Ther Nucleic Acids. 2022 Jan 1;27:699-717

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.41mL

0.28mL

0.14mL

7.05mL

1.41mL

0.71mL

14.11mL

2.82mL

1.41mL

 

Historical Records

Categories